RenovoRx, Inc.
RNXT·NasdaqCM
1.2500−0.0300 (−2.34%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours1.2475−0.0025 (−0.20%)Oct 12, 7:49 PM EDT
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close1.2800
Open1.2600
Day range1.25001.3200
52-week range0.70102.5900
Off day high−5.30%
Off 52-week high−51.74%
Volume253.04K
Avg. volume (3M)777.71K
Market cap56.41M
EPS (TTM)-0.3100
Forward P/E-10.42
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding45.13M
Short interest—
Earnings dateNov 9, 2026 (est.)
Analyst target—
Profit margin—
Against its peers
Compare in full ›| RNXT | NBP | CSBR | RLMD | AARD | VOGX | |
|---|---|---|---|---|---|---|
| Market cap | 56.41M | 153.12M | 68.94M | 374.41M | 97.39M | 254.62M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -10.4 | -1.2 | 49.5 | -8.6 | -1.9 | — |
| Price/book | 6.3 | 0.8 | 17.7 | 1.8 | 1.3 | -50.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +18.52% | −75.91% | −25.65% | +67.82% | −70.03% | +35.08% |
| Today | −2.34% | −5.38% | −0.54% | +3.54% | −6.51% | −2.39% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All RNXT news ›RenovoRx Announces Peer-Reviewed Publication Highlighting the TAMP Platform's Potential to Improve Chemotherapeutic Delivery for Locally Advanced Pancreatic Cancer
Investing News Network RenovoRx Announces Peer-Reviewed Publication Highlighting the TAMP Platform's Potential to Improve Chemotherapeutic Delivery for Locally Advanced Pancreatic Cancer RenovoRx, Inc. ("RenovoRx" or "the Company")…
From articles in the 4Search news index.